Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for its cancer drug Tremelimumab Concentrate
According to the sources, Bharat Biotech which has completed the Phase 2/3 trials of Covid-19 vaccine Covaxin for use in children under 18 years of age has submitted the data to the Central Drugs Standard Control Organisation for its verification and subsequent approval for Emergency Use Authorisation
Johnson & Johnson (J&J) on Friday said it has submitted an application to the Indian drug regulator to conduct a study of its Covid-19 vaccine in adolescents aged 12-17 years. The US-based pharmaceutical company noted that it is committed to facilitating global equitable access to
